MedPage Today April 3, 2024
— Facilitated telemedicine embedded into opioid treatment programs boosted HCV cure rates
Facilitated telemedicine integrated into an opioid treatment program led to better hepatitis C virus (HCV) cure rates compared with usual referral-based care, a randomized clinical trial showed.
In an intention-to-treat analysis, sustained virologic response (SVR) rates were substantially higher for those who had facilitated telemedicine compared with those referred for usual care (90.3% vs 39.4%), with a nearly threefold higher odds of achieving a cure (OR 2.9, 95% CI 2.0-3.5, P<0.001), Andrew Talal, MD, MPH, of the University at Buffalo, and colleagues reported in JAMA.
Notably, illicit drug use fell off significantly among cured participants in both the referral (P=0.001) and the facilitated telemedicine (P<0.001) groups, and few...
Today's Sponsors
Today's Sponsor